摘要
终末期肾功能衰竭患者的病死率远高于与之年龄匹配的普通人群,由于心血管事件造成的死亡占总死亡原因的50%以上.一些非传统的尿毒症及与透析相关的危险因素如贫血、营养不良、高磷血症及高钙磷乘积等,现已被证实参与了心血管疾病(CVD)的发生及发展.其中钙磷代谢紊乱及与之相关的血管钙化发生率增加受到了广泛关注,血管钙化与粥样硬化斑块数量、心肌梗死和心脏骤停等心血管事件均密切相关.现就慢性肾功能衰竭血管钙化的研究进展作一综述.
出处
《上海医学》
CAS
CSCD
北大核心
2007年第7期553-556,共4页
Shanghai Medical Journal
参考文献27
-
1Moe SM,O'Neill KD,Duan D,et al.Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins.Kidney Int,2002,61:638-647.
-
2London GM,Guerin AP,Marchais SJ,et al.Arterial media calcification in end-stage renal disease:impact on all-cause and cardiovascular mortality.Nephrol Dial Transplant,2003,18:1731-1740.
-
3Block GA,Hulbert-Shearon TE,Levin NW,et al.Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients:a national study.Am J Kidney Dis,1998,31:607-617.
-
4Ganesh SK,Stack AG,Levin NW,et al.Association of elevated serum PO(4),Ca x PO(4) product,and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.J Am Soc Nephrol,2001,12:2131-2138.
-
5Goodman WG,Goldin J,Kuizon BD,et al.Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.N Engl J Med,2000,342:1478-1483.
-
6Chertow GM,Burke SK,Raggi P,et al.Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.Kidney Int,2002,62:245-252.
-
7Chertow GM,Burke SK,Dillon MA,et al.Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients.Nephrol Dial Transplant,1999,14:2907-2914.
-
8Price PA,Buckley JR,Williamson MK.The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries,cartilage,lungs and kidneys in rats.J Nutr,2001,131:2910-2915.
-
9Selye H,Gabbiani G,Strebel R.Sensitization to calciphylaxis by endogenous parathyroid hormone.Endocrinology,1962,71:554-558.
-
10Mallick NP,Berlyne GM.Arterial calcification after vitamin-D therapy in hyperphosphatemic renal failure.Lancet,1968,2:1316-1320.
同被引文献18
-
1黄颂敏,柳飞.慢性肾脏疾病与血管钙化[J].中国中西医结合肾病杂志,2006,7(4):187-191. 被引量:1
-
2Covic A,Kanbay M,Voroneanu L.Vascular calcification in chro-nic kidney disease. Clinical Science . 2010
-
3Lomashvili KA,Garg P,Narisawa S.Upregulation of alkaline phosphatase and pyrophosphate hydrolysis:Potential mechanism for uremic vascular calcification. Kidney International . 2008
-
4Mizobuchi M,Towler D,Slatopolsky E.Vascular calcification:the killer of patients with chronic kidney disease. Journal of the American Society of Nephrology . 2009
-
5Moe SM,Chen NX.Mechanisms of vascular calcification in chronic kidney disease. Journal of the American Society of Nephrology . 2008
-
6Price P A,Caputo J M,Williamson M.Bone origin of the serumcomplex of calcium,phosphate,fetuin,and matrix Gla protein:biochemical evidence for the cancellous bone-remodeling com-part ment. Journal of Bone and Mineral Research . 2002
-
7Cecillia M Giachelli.Vascular calcification mechanisms. Journal of American Society of Nephrology . 2004
-
8El-Abbadi M,Giachelli CM.Mechanisms of vascular calcification. Adv Chronic Kidney Dis . 2007
-
9Abedin M,Tintut Y,Demer LL.Vascular calcification: mechanisms and clinical ramifications. Arteriosclerosis . 2004
-
10Luo G,Ducy P,McKee MD,et al.Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature . 1997
-
1曹雪莹.终末期肾脏病患者腹膜透析相关感染分析及预防研究进展[J].湖南中医药大学学报,2012,32(12):76-77. 被引量:1
-
2王金泉.C反应蛋白在终末期肾功能衰竭患者冠状动脉粥样硬化中的作用[J].肾脏病与透析肾移植杂志,2002,11(1):72-76. 被引量:5
-
3吴素蓉,蔡玉兰,蔡光华,余满琼,刘荣华.终末期肾功能衰竭患者动静脉内瘘围术期的护理体会[J].实用医技杂志,2011,18(2):220-221.
-
4冯启红,张艳玲.维持性血液透析患者的心理护理[J].华北煤炭医学院学报,2002,4(3):365-366.
-
5周素素,郭静洁.利多卡因治疗尿毒症患者皮肤瘙痒的护理[J].护理与康复,2006,5(5):389-390. 被引量:3
-
6俎玉焕,梁娟.血液透析对终末期肾功能衰竭高血压的疗效[J].海南医学,2003,14(5):55-55.
-
7钱家麒,张敏芳.慢性肾衰竭与血管钙化[J].中国中西医结合肾病杂志,2007,8(5):249-251. 被引量:8
-
8李颖.高通量血液透析与血液透析滤过对终末期肾功能衰竭患者认知功能的影响[J].中国医药导刊,2012,14(7):1120-1121. 被引量:15
-
9高秀林,李士梅,朱兰英,李志平,严英硕.透析相关低氧血症的临床意义及纠正方法[J].临床泌尿外科杂志,1989,4(1):12-14. 被引量:3
-
10胡作祥,沈水娟,王时敏,李青华.终末期肾功能衰竭患者并发感染临床分析[J].现代中西医结合杂志,2006,15(6):730-731. 被引量:1